Pacira BioSciences, Inc. Income Statement
PCRX / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Pacira BioSciences, Inc. reported $726M in revenue and $7M in net income for FY2025. Revenue has grown at a 31.5% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $726.4M | $701.0M | $675.0M | $666.8M | $421.0M | $337.3M | $286.6M | $276.4M | $249.0M | $276.4M | $249.0M | $197.7M | $15.7M | $14.6M | $15.7M |
| Cost of Revenue | $149.7M | $170.4M | $184.7M | $199.3M | $106.7M | $86.8M | $87.9M | $110.1M | $71.8M | $110.1M | $71.8M | $77.4M | $16.7M | $12.3M | $16.7M |
| SG&A Expense | $368.8M | $294.1M | $269.4M | $254.5M | $200.8M | $177.3M | $161.5M | $152.6M | $139.0M | $152.6M | $139.0M | $106.7M | $20.2M | $6.4M | $20.2M |
| R&D Expense | $117.3M | $81.6M | $76.3M | $84.8M | $72.1M | $55.7M | $57.3M | $45.7M | $28.7M | $45.7M | $28.7M | $18.7M | $14.9M | $18.6M | $14.9M |
| Operating Income | $19.2M | -$73.4M | $87.7M | $60.0M | $10.5M | $15.9M | -$24.9M | -$32.0M | $9.5M | -$32.0M | $9.5M | -$5.2M | -$39.1M | -$22.7M | -$39.1M |
| Interest Expense | $17.4M | $16.6M | $20.3M | $40.0M | $23.6M | $21.9M | $18.0M | $7.1M | $7.7M | $7.1M | $7.7M | $8.3M | $4.8M | $4.0M | $4.8M |
| Income Tax | $9.8M | $36.5M | $19.7M | -$2.6M | $268.0K | $46.0K | $140.0K | $105.0K | $264.0K | $105.0K | $264.0K | $173.0K | $0 | - | $0 |
| Net Income | $7.0M | -$99.6M | $42.0M | $15.9M | -$11.0M | -$471.0K | -$42.6M | -$37.9M | $1.9M | -$37.9M | $1.9M | -$13.7M | -$43.3M | -$27.1M | -$43.3M |
| EPS (Basic) | $0.91 | -$2.15 | $0.95 | $3.41 | -$0.27 | -$0.01 | -$0.07 | - | $0.05 | $0.05 | -$1.93 | -$0.34 | - | - | - |
| EPS (Diluted) | $0.89 | -$2.15 | $0.92 | $3.33 | -$0.27 | -$0.01 | -$0.07 | -$1.02 | $0.04 | $0.04 | -$1.93 | -$0.34 | -$2.64 | -$47.29 | -$55.32 |
| Shares Outstanding | 46.2M | 46.2M | 45.9M | 44.7M | 43.6M | 41.9M | 41.2M | 40.7M | 37.5M | 36.8M | 36.2M | 33.6M | 32.6M | 25.3M | 574.0K |
| Operating Margin | 2.6% | -10.5% | 13.0% | 9.0% | 2.5% | 4.7% | -8.7% | -11.6% | 3.8% | -11.6% | 3.8% | -2.6% | -249.2% | -156.0% | -249.2% |
| Profit Margin | 1.0% | -14.2% | 6.2% | 2.4% | -2.6% | -0.1% | -14.9% | -13.7% | 0.8% | -13.7% | 0.8% | -6.9% | -276.2% | -186.4% | -276.2% |